Key result
Glutaraldehyde fixation of venous valves resulted in a 27.2 ± 14.8% reduction in geometric orifice area compared to native tissue (p < 0.05), with no significant difference in opening/closing time.
Why the study?
Does glutaraldehyde treatment affect the geometric orifice area and opening/closing time of venous valves in an in vitro model?
Does glutaraldehyde treatment affect the geometric orifice area and opening/closing time of venous valves in an in vitro model?
Glutaraldehyde treatment of venous valves significantly reduces their geometric orifice area, indicating decreased flow and highlighting a limitation of traditional tissue treatment methods.
Answers are grounded in this paper and cite their sources.
May limit flow through fixed venous valves; hypothesis-generating for alternative preservation in bioprosthetic design.
OBJECTIVES: The purpose of this study is to test venous valve performance and identify differences between native tissue and replacement devices developed with traditional tissue treatment methods using a new in vitro model with synchronized hemodynamic parameters and high-speed valve image acquisition. METHODS: An in vitro model mimicking the venous circulation to test valve performance was developed using hydrostatic pressure driven flow. Fresh and glutaraldehyde-treated vein segments were placed in the setup and opening/closing of the valves was captured by a high-speed camera. Hemodynamic data were obtained using synchronized hardware and virtual instrumentation. RESULTS: Geometric orifice area and opening/closing time of the valves was evaluated at the same hemodynamic conditions. A reduction in geometric orifice area of 27.2 ± 14.8% (p < 0.05) was observed following glutaraldehyde fixation. No significant difference in opening/closing time following chemical fixation was observed. CONCLUSIONS: The developed in vitro model was shown to be an effective method for measuring the performance of venous valves. The observed decrease in geometric orifice area following glutaraldehyde treatment indicates a decrease in flow through the valve, demonstrating the consequences of traditional tissue treatment methods.
No takes yet. Share an insight, caveat, or question.
Easson et al. (2018) studied Venous valve performance. Glutaraldehyde treatment vs. Fresh (native) vein segments was evaluated on Geometric orifice area and opening/closing time (reduction of 27.2 ± 14.8%, p=< 0.05). Glutaraldehyde fixation of venous valves resulted in a 27.2 ± 14.8% reduction in geometric orifice area compared to native tissue (p < 0.05), with no significant difference in opening/closing time.
Synapse has enriched 10 related papers. Consider them for comparative context: